| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.13B | 16.13B | 13.07B | 12.31B | 16.02B | 11.80B |
| Gross Profit | 5.60B | 5.24B | 4.20B | 3.92B | 5.15B | 4.04B |
| EBITDA | 3.99B | 3.69B | 3.50B | 2.74B | 3.78B | 2.98B |
| Net Income | 3.27B | 3.08B | 2.49B | 2.26B | 3.05B | 2.39B |
Balance Sheet | ||||||
| Total Assets | 33.67B | 31.15B | 29.09B | 25.79B | 26.15B | 23.39B |
| Cash, Cash Equivalents and Short-Term Investments | 9.07B | 8.68B | 10.95B | 9.82B | 10.46B | 8.61B |
| Total Debt | 2.44B | 2.09B | 2.75B | 1.44B | 2.16B | 1.32B |
| Total Liabilities | 12.02B | 10.28B | 10.25B | 8.75B | 10.22B | 8.61B |
| Stockholders Equity | 21.63B | 20.85B | 18.82B | 17.01B | 15.93B | 14.78B |
Cash Flow | ||||||
| Free Cash Flow | 1.20B | 919.13M | 897.00M | 313.57M | 2.20B | 2.64B |
| Operating Cash Flow | 2.30B | 2.10B | 2.01B | 1.78B | 3.12B | 3.28B |
| Investing Cash Flow | -1.26B | -3.08B | -701.96M | 171.31M | -2.27B | -751.29M |
| Financing Cash Flow | -891.39M | -1.72B | 544.17M | -1.95B | -1.01B | -318.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$8.53B | 10.00 | 10.93% | 1.57% | -13.95% | -13.61% | |
75 Outperform | HK$32.56B | 9.88 | 14.66% | 3.32% | 16.15% | 17.32% | |
73 Outperform | HK$15.12B | 12.66 | 13.39% | 3.23% | 2.87% | 17.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$1.02B | 4.73 | 4.79% | 7.16% | 17.21% | 29.75% | |
60 Neutral | HK$3.77B | 11.70 | 17.97% | 2.25% | 14.32% | -19.44% | |
44 Neutral | HK$14.67B | -168.92 | -8.33% | ― | 36.55% | 32.06% |